SOC/BIO Re: Forbes on Populism vs. "BigPharma"

From: Brian D Williams (talon57@well.com)
Date: Mon Nov 27 2000 - 08:27:45 MST


>From: GBurch1@aol.com

>Here's an interesting article that discusses the interrelationship
>of contemporary "anticorporate" populism, intellectual property
>law and pharmaceuticcal companies:

>http://www.forbes.com/global/2000/1127/0324170a.html

An interesting article. The drug companies have been using a bad
economic model that depended on the government running interference
for them. Now that the "cat is out of the bag" they will have to
adopt a more realistic, free market model.

Extropian investors beware during the interim.

One thing I thought the article failed to point out is that if
those who do not understand TANSTAAFL get their way they could
easily kill the "goose that lays the golden eggs", in other words
if pharmaceutical companies intellectual property is compromised,
they will not generate any more or at least dramatically less.

Socialism's fatal flaw. (incentive/costs)

Brian

Member:
Extropy Institute, www.extropy.org
Adler Planetarium www.adlerplanetarium.org
Life Extension Foundation, www.lef.org
National Rifle Association, www.nra.org, 1.800.672.3888
Ameritech Data Center Chicago, IL, Local 134 I.B.E.W



This archive was generated by hypermail 2b30 : Mon May 28 2001 - 09:50:31 MDT